Singapore, April 11 -- In a major step toward democratising access to advanced healthcare, Burjeel Holdings, a leading super-specialty healthcare provider in the Middle East and North Africa (MENA) region, and Caring Cross, a US-based non-profit dedicated to accelerating the development and delivery of advanced medicines, have announced a landmark partnership.

This collaboration will enable the local manufacturing of CAR-T (Chimeric Antigen Receptor T-cell) and stem cell gene therapies in the region. By significantly reducing costs and enhancing regional availability, the partnership aims to make lifesaving, next-generation treatments accessible to patients in the region who previously had limited access to such cutting-edge care.

CAR-T...